Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes
Journal of Visualized Experiments · 2023
DOI: 10.3791/65525 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2023. Written by Vanessa C C Luz and 5 co-authors. Institution: Associate Laboratory i4HB - Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa; UCIBIO - Applied…. Major MEDLINE topics: N-Acetylneuraminic Acid, Monocytes. Cited 2 times so far (Crossref); 58 references.
Abstract (original language)
Sialic acids are negatively charged monosaccharides typically found at the termini of cell surface glycans. Due to their hydrophilicity and biophysical characteristics, they are involved in numerous biological processes, such as modulation of the immune response, recognition of self and non-self antigens, carbohydrate-protein interactions, etc. The cellular content of sialic acid is regulated by sialidase, which catalyzes the removal of sialic acid residues. Several studies have shown that sialo-glycans are critical in monitoring immune surveillance by engaging with cis and trans inhibitory Siglec receptors on immune cells. Likewise, glyco-immune checkpoints in cancer are becoming crucial targets for developing immunotherapies. Additionally, dendritic cells (DCs) are envisioned as an important component in immunotherapies, especially in cancer research, due to their unique role as professional antigen-presenting cells (APC) and their capacity to trigger adaptive immune responses and generate immunologic memory. Nevertheless, the function of DCs is dependent on their full maturation. Immature DCs have an opposing function to mature DCs and a high sialic acid content, which further dampens their maturation level. This downregulates the ability of immature DCs to activate T-cells, leading to a compromised immune response. Consequently, removing sialic acid from the cell surface of human DCs induces their maturation, thus increasing the expression of MHC molecules and antigen presentation. In addition, it can restore the expression of co-stimulatory molecules and IL-12, resulting in DCs having a higher ability to polarize T-cells toward a Th1 phenotype and specifically activate cytotoxic T-cells to kill tumor cells. Therefore, sialic acid has emerged as a key modulator of DCs and is being used as a novel target to advance their therapeutic use. This study provides a unique approach to treat in vitro monocyte-derived DCs with sialidase, aimed at generating DC populations with different cell surface sialic acid phenotypes and tailored maturation and co-stimulatory profiles.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Associate Laboratory i4HB - Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa; UCIBIO - Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School…
- Department of Microbiology and Immunology, Albert Einstein College of Medicine; Department of Oncology, Albert Einstein College of Medicine.
- Stemmatters, Biotecnologia e Medicina Regenerativa SA, Parque de Ciência e Tecnologia Avepark, Zona Industrial da Gandra.
Cite
APA
Luz, V. C. C., Silva, Z., Sobral, P., Tanwar, A., Paterson, R. L., & Videira, P. A. (2023). Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes. Journal of Visualized Experiments. https://doi.org/10.3791/65525
Vancouver
Luz VCC, Silva Z, Sobral P, Tanwar A, Paterson RL, Videira PA. Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes. Journal of Visualized Experiments. 2023. doi:10.3791/65525
BibTeX
@article{Luz2023,
author = {Luz, Vanessa C C and Silva, Zélia and Sobral, Patrícia and Tanwar, Ankit and Paterson, Rachel L and Videira, Paula A},
title = {Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes},
journal = {Journal of Visualized Experiments},
year = {2023},
doi = {10.3791/65525}
}
EUVIMED